文献速递哮喘

成人及儿童哮喘诊断的挑战与未来方向

[Personal View] Asthma diagnosis in adults and children: challenges, future directions, and a call to action
RSS 订阅 · The Lancet Respiratory Medicine

哮喘是全球最常见的慢性气道疾病,定义为以波动性呼吸道症状和可变性呼气气流受限为特征的异质性临床综合征。尽管有明确定义,哮喘误诊率仍很高:20–70%的哮喘患者未确诊和未治疗,约30%被标记为哮喘的个体实际并无该病。客观证据结合症状变异性对支持哮喘诊断至关重要。

要点

  • 20–70%的哮喘患者未确诊和未治疗。
  • 约30%被标记为哮喘的个体实际无该病。
  • 客观证据结合症状变异性是诊断关键。

核心结论

  • 哮喘误诊率高,需客观证据结合症状变异性支持诊断。

主要发现

  • 20–70%的哮喘患者未确诊和未治疗。
  • 约30%被标记为哮喘的个体实际无该病。

关键数值与推荐

  • 哮喘定义为以波动性呼吸道症状和可变性呼气气流受限为特征的异质性临床综合征。
  • 客观证据结合症状变异性对支持哮喘诊断至关重要。

临床怎么用

  • 临床诊断哮喘应结合客观证据和症状变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden. Asthma is generally defined as a heterogeneous clinical syndrome characterised by fluctuating respiratory symptoms and variable expiratory airflow limitation. Despite this definition, asthma misdiagnosis remains high; 20–70% of individuals with asthma remain undiagnosed and untreated, and approximately 30% of those labelled as having asthma do not have the disease. Objective evidence, alongside variability of symptoms, is essential to support a diagnosis of asthma.

来源:The Lancet Respiratory Medicine,查看原文。版权归原作者所有。

引用

  1. The Lancet Respiratory Medicine:[Personal View] Asthma diagnosis in adults and children: challenges, future directions, and a call to action

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。